Chris Xu
2021
In 2021, Chris Xu earned a total compensation of $748K as Chief Executive Officer at Cesca Therapeutics, a 63% decrease compared to previous year.
Compensation breakdown
| Bonus | $248,000 |
|---|---|
| Salary | $500,000 |
| Total | $748,000 |
Xu received $500K in salary, accounting for 67% of the total pay in 2021.
Xu also received $248K in bonus.
Rankings
In 2021, Chris Xu's compensation ranked 9,692nd out of 12,415 executives tracked by ExecPay. In other words, Xu earned more than 21.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,692 out of 12,415 | 22nd |
Division Manufacturing | 4,295 out of 5,505 | 22nd |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 576 out of 801 | 28th |
Industry group Laboratory Apparatus And Analytical, Optical, Measuring, and Controlling Instruments | 154 out of 206 | 25th |
Industry Laboratory Apparatus and Furniture | 1 out of 5 | 80th |
Source: SEC filing on November 1, 2022.
Xu's colleagues
We found one more compensation record of an executive who worked with Chris Xu at Cesca Therapeutics in 2021.
2021
Jeffery Cauble
Cesca Therapeutics
Chief Financial Officer
News
Cesca Therapeutics CEO Chris Xu's 2022 pay slips 7% to $699K
October 26, 2023
Cesca Therapeutics CEO Chris Xu's 2021 pay falls 63% to $748K
November 1, 2022
Cesca Therapeutics CEO Chris Xu's 2020 pay jumps 323% to $2M
November 5, 2021
Cesca Therapeutics CEO Chris Xu's 2019 pay falls 28% to $472K
April 21, 2020